Literature DB >> 18931598

Probiotics in allergy management.

Jon A Vanderhoof1.   

Abstract

The gut contains a diverse bacterial flora that is acquired at birth and has a number of physiological functions. Administration of prebiotics or probiotics may favourably alter this gut microflora. Prebiotics are poorly digested oligosaccharides that promote the growth of desirable bacteria and may have other beneficial gastrointestinal and systemic effects. Probiotics are "helpful" human bacteria that provide a variety of health benefits when administered exogenously. Probiotics produce beneficial effects in the prevention and treatment of traveller's diarrhoea, viral diarrhoea, and diarrhoea in day care centres. Moreover, probiotics have been shown to reduce relapses associated with Clostridium difficile, and Lactobacilli are effective in the prevention of antibiotic-associated diarrhoea. Probiotics may also be efficacious in the treatment of gastroenteritis. Clinical studies of probiotics in inflammatory bowel disease have proved disappointing, but beneficial effects in adults with irritable bowel syndrome have been reported with Bifidobacterium infantis 35624. Lactobacilli GG reduces the incidence of gastrointestinal symptoms and gut permeability in patients with atopic dermatitis, and administration of probiotics reduces the frequency and severity of atopic eczema when administered to pregnant women and then to newborn infants. In conclusion, probiotics are effective in the treatment and/or prevention of a number of conditions, including diarrhoea, irritable bowel syndrome and atopic dermatitis, and the product used should be selected based on the particular indication.

Entities:  

Mesh:

Year:  2008        PMID: 18931598     DOI: 10.1097/01.mpg.0000338810.74933.c1

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  9 in total

1.  Toward an Alternative Therapeutic Approach for Skin Infections: Antagonistic Activity of Lactobacilli Against Antibiotic-Resistant Staphylococcus aureus and Pseudomonas aeruginosa.

Authors:  Mohamed M Hafez; Ibrahim A Maghrabi; Noha M Zaki
Journal:  Probiotics Antimicrob Proteins       Date:  2013-09       Impact factor: 4.609

Review 2.  Possible links between intestinal permeability and food processing: A potential therapeutic niche for glutamine.

Authors:  Jean Robert Rapin; Nicolas Wiernsperger
Journal:  Clinics (Sao Paulo)       Date:  2010-06       Impact factor: 2.365

3.  Probiotics and their Effects on Metabolic Diseases: An Update.

Authors:  Juhi Aggarwal; Gaurav Swami; Mayur Kumar
Journal:  J Clin Diagn Res       Date:  2013-01-01

Review 4.  Folate production by probiotic bacteria.

Authors:  Maddalena Rossi; Alberto Amaretti; Stefano Raimondi
Journal:  Nutrients       Date:  2011-01-18       Impact factor: 5.717

5.  Lactobacillus rhamnosus GR-1 enhances NF-kappaB activation in Escherichia coli-stimulated urinary bladder cells through TLR4.

Authors:  Mattias Karlsson; Nikolai Scherbak; Gregor Reid; Jana Jass
Journal:  BMC Microbiol       Date:  2012-01-22       Impact factor: 3.605

6.  Efficacy of Probiotic Therapy on Atopic Dermatitis in Children: A Randomized, Double-blind, Placebo-controlled Trial.

Authors:  Hyeon-Jong Yang; Taek Ki Min; Hae Won Lee; Bok Yang Pyun
Journal:  Allergy Asthma Immunol Res       Date:  2013-12-12       Impact factor: 5.764

7.  A study of the effects of therapeutic doses of ionizing radiation in vitro on Lactobacillus isolates originating from the vagina - a pilot study.

Authors:  Tomasz Gosiewski; Tomasz Mróz; Dorota Ochońska; Wojciech Pabian; Malgorzata Bulanda; Monika Brzychczy-Wloch
Journal:  BMC Microbiol       Date:  2016-05-31       Impact factor: 3.605

8.  Assessing worldwide research activity on probiotics in pediatrics using Scopus database: 1994-2014.

Authors:  Waleed M Sweileh; Naser Y Shraim; Samah W Al-Jabi; Ansam F Sawalha; Belal Rahhal; Rasha A Khayyat; Sa'ed H Zyoud
Journal:  World Allergy Organ J       Date:  2016-07-25       Impact factor: 4.084

9.  Antiviral activity of Lactobacillus reuteri Protectis against Coxsackievirus A and Enterovirus 71 infection in human skeletal muscle and colon cell lines.

Authors:  Lei Yin Emily Ang; Horng Khit Issac Too; Eng Lee Tan; Tak-Kwong Vincent Chow; Lynette Pei-Chi Shek; Elizabeth Huiwen Tham; Sylvie Alonso
Journal:  Virol J       Date:  2016-06-24       Impact factor: 4.099

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.